CCR5 and HIV infectious disease: We speculate that the presence of this potential gateway on myeloid cells explains the long-observed phenomenon that native chemokines are much less effective at protecting macrophages from CCR5-mediated HIV infection than they are at protecting CD4+ T cells [8, 13, , , , –18, 73].